M. ten Ham, “Health Risks of Counterfeit Pharmaceuticals,” Drug Safety, Vol. 26, No. 14, 2003, pp. 991-997 http://dx.doi.org/10.2165/00002018-200326140-00001
 S. E. Nsimba, “Problems Associated with Substandard and Counterfeit Drugs in Developing Countries: A Review Article on Global Implications of Counterfeit Drugs in the Era of Antiretroviral (ARVs) Drugs in a Free Market Economy,” East African Journal of Public Health, Vol. 5, No. 3, 2008, pp. 205-210.
 T. Kelesidis, I. Kelesidis, P. I. Rafailidis and M. E. Falagas, “Counterfeit or Substandard Antimicrobial Drugs: A Review of the Scientific Evidence,” Journal of Antimicrobial Chemotherapy, Vol. 60, No. 2, 2007, pp. 214-236. http://dx.doi.org/10.1093/jac/dkm109
 R. Watson, “European Union Prepares to Tackle Counterfeit Drugs,” British Medical Journal, Vol. 340, 2010, p. c2425. http://dx.doi.org/10.1136/bmj.c2425
 E. Wondemagegnehu, “Counterfeit and Substandard Drugs in Myanmar and Viet Nam—Report of a Study Carried out in Cooperation with the Governments of Myanmar and Viet Nam,” 2011. http://apps.who.int/medicinedocs/pdf/s2276e/s2276e.pdf
 M. H. Khan, J. Okumura, T. Sovannarith, N. Nivanna, M. Akazawa and K. Kimura, “Prevalence of Counterfeit Anthelminthic Medicines: A Cross-Sectional Survey in Cambodia,” Tropical Medicine and International Health, Vol. 15, No. 5, 2010, pp. 639-644. http://dx.doi.org/10.1111/j.1365-3156.2010.02494.x
 P. N. Newton, M. D. Green, D. C. Mildenhall, A. Plancon, H. Nettey, L. Nyadong, D. M. Hostetler, I. Swamidoss, G. A. Harris, K. Powell, A. E. Timmermans, A. A. Amin, S. K. Opuni, S. Barbereau, C. Faurant, R. C. W. Soong, K. Faure, J. Thevanayagam, P. Fernandes, H. Kaur, B. Angus, K. Stepniewska, P. J. Guerin and F. M. Fernández, “Poor Quality Vital Anti-Malarials in Africa—An Urgent Neglected Public Health Priority,” Malaria Journal, Vol. 10, 2011, p. 352. http://dx.doi.org/10.1186/1475-2875-10-352
 S. Kyriacos, M. Mroueh, R. P. Chahine and O. Khouzam, “Quality of Amoxicillin Formulations in Some Arab Countries,” Journal of Clinical Pharmacy and Therapeutics, Vol. 33, No. 4, 2008, pp. 375-379. http://dx.doi.org/10.1111/j.1365-2710.2008.00926.x
 World Health Organization, “Counterfeit Drugs. Guidelines for the Development of Measures to Combat Counterfeit Drugs,” 2011. http://whqlibdoc.who.int/hq/1999/WHO_EDM_QSM_99.1.pdf
 World Health Organization, “Counterfeit Medicines: Some Frequently Asked Questions,” 2011. http://www.wpro.who.int/mediacentre/factsheets/fs_20050506/en/index.html
 P. N. Newton, S. J. Lee, C. Goodman, F. M. Fernández, S. Yeung, S. Phanouvong, H. Kaur, A. A. Amin, C. J. M. Whitty, G. O. Kokwaro, N. Lindegardh, P. Lukulay, L. J. White, N. P. J. Day, M. D. Green and N. J. White, “Guidelines for Field Surveys of the Quality of Medicines: A Proposal,” PLoS Medicine, Vol. 6, No. 3, 2009, Article ID: e1000052. http://dx.doi.org/10.1371/journal.pmed.1000052
 W. A. Reinke, “Applicability of Industrial Sampling Techniques to Epidemiologic Investigations: Examination of an Underutilized Resource,” American Journal of Epidemiology, Vol. 134, No. 10, 1991, pp. 1222-1232.
 S. E. Robertson and J. J. Valadez, “Global Review of Health Care Surveys Using Lot Quality Assurance Sampling (LQAS), 1984-2004,” Social Science & Medicine, Vol. 63, No. 6, 2006, pp. 1648-1660. http://dx.doi.org/10.1016/j.socscimed.2006.04.011
 A. Bhuiya, S. M. A. Hanifi, N. Roy and P. K. Streatfield, “Performance of the Lot Quality Assurance Sampling Method Compared to Surveillance for Identifying Inadequately-Performing Areas in Matlab, Bangladesh,” Journal of Health, Population, and Nutrition, Vol. 25, No. 1, 2007, pp. 37-46.
 A. A. Bin Abdulhak, M. A. Altannir, M. A. Almansor, M. S. Almohaya, A. S. Onazi, M. A. Marei, O. F. Aldossary, S. A. Obeidat, M. A. Obeidat, M. S. Riaz and I. M. Tleyjeh, “Non Prescribed Sale of Antibiotics in Riyadh, Saudi Arabia: A Cross Sectional Study,” BMC Public Health, Vol. 11, No. 1, 2011, p. 538. http://www.biomedcentral.com/1471-2458/11/538 http://dx.doi.org/10.1186/1471-2458-11-538
 Saudi Food and Drug Authority, “About SFDA,” 2012. http://old.sfda.gov.sa/En/Home/Topics/about/ http://www.sfda.gov.sa/en/about/Pages/overview.aspx
 World Health Organization, “17th Model List of Essential Medicines,” 2012.
 Saudi Ministry of Health, “Formulary: Drug List,” 2012.
 K. K. Naidoo, P. Nompuku, S. N. Mkalali, K. Shabangu, L. Nkabinde and V. Singh, “Post-Marketing Stability Surveillance: Amoxicillin,” South African Family Practice, Vol. 48, No. 6, 2006, pp. 14-14d. http://www.safpj.co.za/index.php/safpj/article/view/609/541
 R. B. Taylor, O. Shakoor, R. H. Behrens, M. Everard, A. S. Low, J. Wangboonskul, R. G. Reid and J. A. Kolawole, “Pharmacopeial Quality of Drugs Supplied by Nigerian Pharmacies,” The Lancet, Vol. 357, No. 9272, 2011, pp. 1933-1936. http://dx.doi.org/10.1016/S0140-6736(00)05065-0
 U. Hadi, P. van den Broek, E. P. Kolopaking, N. Zairina, W. Gardjito and I. C. Gyssens, “Cross-Sectional Study of Availability and Pharmaceutical Quality of Antibiotics Requested with or without Prescription (over the Counter) in Surabaya, Indonesia,” BMC Infectious Diseases, Vol. 10, No. 1, 2010, p. 203. http://dx.doi.org/10.1186/1471-2334-10-203
 B. L. Hedt, C. Olives, M. Pagano and J. Valadez, “Large Country-Lot Quality Assurance Sampling: A New Method for Rapid Monitoring and Evaluation of Health, Nutrition and Population Programs at Sub-National Levels,” The International Bank for Reconstruction and Development/The World Bank, Washington DC, 2008, pp. 31-32.
 J. J. Valadez, R. Transgrud, M. Mbugua and T. Smith, “Assessing Family Planning Service-Delivery Skills in Kenya,” Studies in Family Planning, Vol. 28, No. 2, 1997, pp. 143-150. http://dx.doi.org/10.2307/2138116
 Food and Nutrition Technical Assistance III Project, “LQAS Sample Size Calculator,” 2012. http://www.fantaproject.org/calculators/samplesize_calculator.shtml
 P. T. Norris, “Purchasing Restricted Medicines in New Zealand Pharmacies: Results from a ‘Mystery Shopper Study’,” Pharmacy World and Science, Vol. 24, No. 4, 2002, pp. 149-153. http://dx.doi.org/10.1023/A:1019506120713
 J. M. Madden, J. D. Quick, D. Ross-Degnan and K. K. Kafle, “Undercover Careseekers: Simulated Clients in the Study of Health Provider Behavior in Developing Countries,” Social Science & Medicine, Vol. 45, No. 10, 1997, pp. 1465-1482. http://dx.doi.org/10.1016/S0277-9536(97)00076-2
 P. De Pourcq, J. Hoebus, E. Roets, J. Hoogmartens and H. Vanderhaeghe, “Quantitative Determination of Amoxicillin and Its Decomposition Products by High-Performance Liquid Chromatography,” Journal of Chromatography, Vol. 321, No. 2, 1985, pp. 441-449. http://dx.doi.org/10.1016/S0021-9673(01)90462-5
 G. W. Fong, D. T. Martin, R. N. Johnson and B. T. Kho, “Determination of Degradation Products and Impurities of Amoxicillin Capsules Using Ternary Gradient Elution High-Performance Liquid Chromatography,” Journal of Chromatography, Vol. 298, No. 3, 1984, pp. 459-472.